THE MARK FOUNDATION FOR CANCER RESEARCH

the-mark-foundation-for-cancer-research-logo

Mark Foundation actively partners with scientists to accelerate research that will transform the prevention, diagnosis, treatment of cancer.

#People #Financial #Event #More

THE MARK FOUNDATION FOR CANCER RESEARCH

Status:
Active


Current Employees Featured

not_available_image

Raymond N. DuBois
Raymond N. DuBois Executive Chairman @ The Mark Foundation for Cancer Research
Executive Chairman
2022-02-01

ryan-schoenfeld_image

Ryan Schoenfeld
Ryan Schoenfeld CEO @ The Mark Foundation for Cancer Research
CEO
2022-05-01

Investments List

Date Company Article Money raised
2022-07-28 Vicinitas Therapeutics The Mark Foundation for Cancer Research investment in Series A - Vicinitas Therapeutics 65 M USD
2021-08-18 Immunitas Therapeutics The Mark Foundation for Cancer Research investment in Series B - Immunitas Therapeutics 58 M USD
2021-05-18 Interius BioTherapeutics The Mark Foundation for Cancer Research investment in Series A - Interius BioTherapeutics 76 M USD
2021-04-15 C2i Genomics The Mark Foundation for Cancer Research investment in Series B - C2i Genomics 100 M USD
2020-06-09 C2i Genomics The Mark Foundation for Cancer Research investment in Series A - C2i Genomics 12 M USD
2020-04-23 Accent Therapeutics The Mark Foundation for Cancer Research investment in Series B - Accent Therapeutics 63 M USD
2020-03-13 Interius BioTherapeutics The Mark Foundation for Cancer Research investment in Venture Round - Interius BioTherapeutics 5.5 M USD
2019-12-18 The Jackson Laboratory The Mark Foundation for Cancer Research investment in Grant - The Jackson Laboratory 2.5 M USD
2019-10-21 Verseau Therapeutics The Mark Foundation for Cancer Research investment in Venture Round - Verseau Therapeutics 50 M USD

More informations about "The Mark Foundation for Cancer Research" on Search Engine